Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\28401010
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 Am+J+Cancer+Res
2017 ; 7
(3
): 543-553
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Downregulation of ACSM3 promotes metastasis and predicts poor prognosis in
hepatocellular carcinoma
#MMPMID28401010
Ruan HY
; Yang C
; Tao XM
; He J
; Wang T
; Wang H
; Wang C
; Jin GZ
; Jin HJ
; Qin WX
Am J Cancer Res
2017[]; 7
(3
): 543-553
PMID28401010
show ga
Understanding mechanisms of cancer metastasis is crucial for reduction of cancer
mortality. Acyl-CoA medium-chain synthetase 3 (ACSM3) is an acyl-CoA synthetase
which takes part in the first step of fatty acid metabolism. However, the
expression, clinical significance and biological function of ACSM3 remain unknown
in hepatocellular carcinoma (HCC). In this study, the expression and prognostic
relevance of ACSM3 were investigated by tissue microarray and HCC clinical
samples. Migration and invasion assays were carried out for functional analysis
in vitro and a xenograft model was used to analyze the effects of ACSM3 on cancer
metastasis in vivo. Furthermore, human phospho-kinase array assays were performed
to explore molecular mechanisms of ACSM3 in HCC. The results showed ACSM3 was
downregulated in HCC tissues. HCC patients with low expression of ACSM3 exhibited
poor prognosis. Overexpression of ACSM3 attenuated migration and invasion of HCC
cells in vitro and in vivo and downregulated the phosphorylation of WNK1 and AKT.
Our findings indicate ACSM3 is a novel prognostic marker and a potential
therapeutic target for HCC.